In Stock, Ready to Ship!

PT-141

$179$359

99% Pure | USA Made | Multi Dose

PT-141 (Bremelanotide) acts on the nervous system to support sexual desire and arousal in both men and women, offering a non-hormonal approach to sexual wellness.

Dosage

$179

1

Pairs well with

Bacteriostatic Water

Required for reconstitution

$12

Note: Peptides are not ready to use. Must purchase BAC water for reconstitution.

Key Benefits

What makes PT-141 exceptional

Every treatment in our catalog is physician-reviewed and pharmacy-compounded. Here's why PT-141 stands out.

Activates melanocortin receptors in the brain to enhance genuine sexual desire

Overview

What is PT-141?

PT-141, also known as Bremelanotide, is a melanocortin receptor agonist that works directly on the central nervous system to enhance sexual desire and arousal. Unlike PDE5 inhibitors that only address blood flow mechanics, PT-141 targets the neurological pathways that govern sexual response, making it effective for both men and women experiencing hypoactive sexual desire.

1.75mg as needed · Subcutaneous injection

Administered under physician guidance

Why choose PT-141?

PT-141 offers a fundamentally different approach to sexual wellness by addressing desire at its source — the brain. Benefits include:

Works on both men and women — one of the only treatments effective for female sexual dysfunction

Addresses desire and arousal, not just mechanical function

Non-hormonal mechanism — won’t interfere with hormone therapies

As-needed dosing — take only when desired, no daily commitment

FDA-approved active ingredient (Bremelanotide/Vyleesi)

The Difference

What sets PT-141 apart

PT-141 is unique because it works on melanocortin receptors (MC3R and MC4R) in the hypothalamus — the brain’s desire center — rather than on the vascular system. This means it enhances genuine sexual desire and arousal rather than simply enabling a physical response, resulting in a more natural and satisfying experience.

Clinical Evidence

Backed by research

Peer-reviewed studies supporting PT-141 treatment protocols.

2019Obstetrics & Gynecology

Bremelanotide for Female Hypoactive Sexual Desire

Significant improvement in sexual desire and reduction of distress in premenopausal women.

Ready to start your treatment?

All orders require physician approval. You're only charged if approved.

Browse all treatments